- ホーム
- > 洋書
- > 英文書
- > Science / Mathematics
Full Description
This book offers a comprehensive overview of the epidemiology, etiology, and pathophysiology of chronic obstructive pulmonary disease (COPD). It addresses the limitations of existing drug delivery methods and explores advanced delivery systems to overcome these challenges, providing an exhaustive account of their intricate mechanisms. The introductory chapters elucidate pathways responsible for COPD progression, followed by a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy. Subsequent chapters provide insights into ongoing treatment modalities, their efficacy, drawbacks, and prospective solutions to counter the setbacks of COPD therapy. The subsequent section covers state-of-the-art drug delivery technologies and novel drug formulations designed to enhance drug deposition and absorption in COPD lungs. It further explores a methodical yet coordinated explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems. Toward the end, the book discusses ongoing and completed clinical trials encompassing the management of COPD through advanced drug delivery approaches. It serves as a valuable resource for professionals, scientists, academicians, and clinicians specializing in respiratory health.
Provides an in-depth understanding of the epidemiology, etiology, and pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)
Delve into pathways responsible for COPD progression, conducting a detailed analysis of established biomarkers and potential targets in contemporary COPD therapy
Offer insights into ongoing treatment modalities, evaluating their efficacy, drawbacks, and proposing prospective solutions to counter the setbacks of COPD therapy
Systematically organizes information on state-of-the-art drug delivery technologies and novel formulations designed to enhance drug deposition and absorption in COPD lungs
Presents a methodical explanation of targeted personalized therapies and emerging approaches, including nanoparticles, polymeric carriers, and vesicular delivery systems
Contents
Chapter 1: Introduction to COPD: Epidemiology, Etiology, and Pathophysiology
Chapter 2: Biomarkers for the Management of Chronic Obstructive Pulmonary Disease
Chapter 3: Current Treatment Modalities for Chronic Obstructive Pulmonary Disease: Challenges and Limitations
Chapter 4: Inhaled Drug Delivery Systems in the Management of Chronic Obstructive Pulmonary Disease
Chapter 5: Advancements in Smart Inhaler Technology for Enhancing Chronic Obstructive Pulmonary Disease Care
Chapter 6: Nanotechnology in Pulmonary Drug Delivery
Chapter 7: Liposomal Drug Delivery in the Management of Chronic Obstructive Pulmonary Disease
Chapter 8: Polymeric Nanoparticles for Targeted Therapy of Chronic Obstructive Pulmonary Disease
Chapter 9: Hybrid Nanocarriers for the Delivery of Therapeutics in Chronic Obstructive Pulmonary Disease
Chapter 10: Dendrimers as Emerging Drug Carriers in Chronic Obstructive Pulmonary Disease
Chapter 11: Biodegradable Polymers for Controlled Release of Drugs in Chronic Obstructive Pulmonary Disease
Chapter 12: Nano-Approaches for the Delivery of Biologics in Chronic Obstructive Pulmonary Disease
Chapter 13: Nano Theranostics for Chronic Obstructive Pulmonary Disease: Status and Implications
Chapter 14: Senolytics: A Potential Therapeutic Approach for COPD Management
Chapter 15: Precision Care: Personalized Medicine in Chronic Obstructive Pulmonary Disease Management
Chapter 16: Digital Health Solutions: Enhancing Medication Adherence in COPD Treatment
Chapter 17: Clinical Trials and Regulatory Issues of Nanocarriers Employed in the Treatment of Chronic Obstructive Pulmonary Disease
Chapter 18: Prospects of Advanced Drug Delivery Systems in Combating Chronic Obstructive Pulmonary Disease
